Phagocytosis of agarose beads by receptors for C3b (CR1) and iC3b (CR3) on alveolar macrophages from patients with sarcoidosis.
Alveolar macrophages (AM) from sarcoidosis patients exhibit no detectable defect in their potential to synthesize the functional alternative and terminal pathway of complement. They also synthesize more C9 than AM from healthy controls. Various authors have suggested that sarcoid AM have decreased phagocytic ability. In the present work we studied whether there was any difference in C3 receptor-mediated phagocytosis of serum-treated and native agarose beads by AM recovered from patients with active sarcoidosis compared with controls. AM from seven patients with active sarcoidosis and seven healthy controls were cultured under serum-free conditions for 2, 12, 24, and 48 h. We found a significantly increased CR1 and CR3 receptor-mediated phagocytosis of native agarose beads by AM from the seven patients. CR1 and CR3 were also detected on AM directly recovered from bronchoalveolar lavage fluid using fluorescein-conjugated monoclonal anti-receptor antibodies. The percentage of AM expressing CR appeared to be increased in sarcoidosis. The reason for the enhanced phagocytosis of agarose beads by the sarcoid AM is probably the result of both increased synthesis and receptors of complement. Altered complement production and complement receptors may be important for the pathogenesis of this granulomatous disorder.
Pettersen
H B
HB
Department of Internal Medicine, University of Trondheim, Norway.
Johnson
E
E
Osen
S S
SS
D000328:Adult; D000911:Antibodies, Monoclonal; D001992:Bronchoalveolar Lavage Fluid; D005260:Female; D019793:Fluorescein; D005452:Fluoresceins; D015726:Giant Cells / Q000473:pathology; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D008264:Macrophages / Q000276:immunology* / Q000648:ultrastructure; D008297:Male; D008855:Microscopy, Electron, Scanning; D008875:Middle Aged; D010587:Phagocytosis / Q000276:immunology; D011650:Pulmonary Alveoli / Q000166:cytology; D011951:Receptors, Complement / Q000502:physiology*; D017463:Receptors, Complement 3b; D012507:Sarcoidosis / Q000276:immunology* / Q000473:pathology; D012685:Sepharose; D013997:Time Factors
D000911:Antibodies, Monoclonal; D005452:Fluoresceins; D006684:HLA-DR Antigens; D011951:Receptors, Complement; D017463:Receptors, Complement 3b; D012685:Sepharose; D019793:Fluorescein